HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brett Leav Selected Research

Human Influenza (Influenza)

10/2021Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
1/2021Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.
1/2020Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002-2003 to 2017-2018.
1/2018Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brett Leav Research Topics

Disease

19COVID-19
12/2024 - 12/2020
4Infections
10/2023 - 12/2020
4Human Influenza (Influenza)
10/2021 - 01/2018
2Chronic Obstructive Pulmonary Disease (COPD)
12/2024 - 11/2023
2Neoplasms (Cancer)
12/2023 - 01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Severe Acute Respiratory Syndrome
03/2022
1Breakthrough Infections
01/2022
1Pain (Aches)
12/2021
1Headache (Headaches)
12/2021
1Fatigue
12/2021
1Asymptomatic Infections
11/2021
1Fever (Fevers)
01/2021
1Rabies (Hydrophobia)
11/2012

Drug/Important Bio-Agent (IBA)

23VaccinesIBA
12/2024 - 11/2012
152019-nCoV Vaccine mRNA-1273IBA
12/2024 - 01/2021
4Proteins (Proteins, Gene)FDA Link
12/2024 - 01/2021
4COVID-19 VaccinesIBA
04/2024 - 01/2023
4Neutralizing AntibodiesIBA
12/2023 - 11/2012
4Messenger RNA (mRNA)IBA
11/2022 - 01/2021
3AntibodiesIBA
12/2024 - 11/2023
3Influenza Vaccines (Influenza Vaccine)FDA Link
12/2024 - 01/2018
2mRNA VaccinesIBA
01/2023 - 01/2022
1Glycoproteins (Glycoprotein)IBA
11/2023
1Herpes Zoster VaccineIBA
11/2023
1NVX-CoV2373 adjuvated lipid nanoparticleIBA
10/2023
1Combined VaccinesIBA
11/2022
1Meningococcal Vaccines (Meningococcal Vaccine)IBA
10/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2021
1Lipid NanoparticlesIBA
01/2021
1GlobulinsIBA
11/2012
1Immunoglobulin G (IgG)IBA
11/2012
1Immunoglobulins (Immunoglobulin)IBA
11/2012
1Rabies Vaccines (Rabies Vaccine)FDA Link
11/2012
1Monoclonal AntibodiesIBA
11/2012

Therapy/Procedure

3Injections
12/2021 - 01/2021
2Intramuscular Injections
11/2021 - 01/2021